BUSINESS NEWS

Laurus Labs inks agreement to acquire 2662 percent stake in Immunoact

Written by admin

Laurus Labs inks agreement to acquire 2662 percent stake in Immunoact

Hyderabad, Nov 19 (PTI) Laurus Labs has tied up with Immunoadaptive Cell Therapy Pvt Ltd (Immunoact), an advanced cell and gene therapy company, to acquire 26.62 per cent stake for about Rs 46 crore. The company gave this information on Friday.

In addition, the senior management of Laurus Labs will also invest in Immunoact for a 5.64 per cent stake for about Rs 9.75 crore at similar price and terms, a release from the Hyderabad-based drugmaker said.

Laurus Labs’ investment in ImmunoAct is part of a larger strategy to strengthen the firm’s biologics business and provides access and penetration into an emerging area of ​​research.

#Laurus #Labs #inks #agreement #acquire #percent #stake #Immunoact

See also  amazon alexa will now be able to ask the address of kovid 19 test vaccination centers

About the author

admin

Leave a Comment

close
%d bloggers like this: